These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7034988)

  • 21. Mutagenic and DNA-damaging effects of N-alkyl-N-(alpha-acetoxyalkyl)nitrosamines, models for metabolically activated N,N-dialkylnitrosamines.
    Mochizuki M; Suzuki E; Anjo T; Wakabayashi Y; Okada M
    Gan; 1979 Oct; 70(5):663-70. PubMed ID: 118074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsome-mediated mutagenesis in V79 Chinese hamster cells by various nitrosamines.
    Kuroki T; Drevon C; Montesano R
    Cancer Res; 1977 Apr; 37(4):1044-50. PubMed ID: 321116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenicity of isomeric alkanediazotates, precursors for ultimate alkylating species of carcinogenic N-nitroso compounds.
    Ukawa-Ishikawa S; Sawada A; Kasuya K; Mochizuki M
    Mutat Res; 1998 Jan; 412(1):99-107. PubMed ID: 9508369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutagenicity of cyclic nitrosamines in Salmonella typhimurium: effect of ring size.
    Rao TK; Ramey DW; Lijinsky W; Epler JL
    Mutat Res; 1979 May; 67(1):21-6. PubMed ID: 379636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds.
    Nagao M; Suzuki E; Yasuo K; Yahagi T; Seino Y
    Cancer Res; 1977 Feb; 37(2):399-407. PubMed ID: 318920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mutagenicity of methylbenzylnitrosamine and its alpha-acetoxy derivatives.
    Tannenbaum SR; Kraft P; Baldwin J; Branz S
    Cancer Lett; 1977 May; 2(6):305-10. PubMed ID: 324607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of the bacterial flocculation test for assessing the mutagenic properties of carcinogenic nitrosamines and nitramines].
    Khudoleĭ VV
    Vopr Onkol; 1982; 28(8):64-8. PubMed ID: 7051551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenicity of 22 N-nitrosamides and related compounds for Salmonella typhimurium TA1535.
    Lee K; Gold B; Mirvish SS
    Mutat Res; 1977 Apr; 48(2):131-8. PubMed ID: 17832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenicity of N-alkyl-N-(alpha-acetoxyalkyl) nitrosamines in V79 Chinese hamster cells in relation to alkylating activity.
    Huang GF; Mochizuki M; Anjo T; Okada M
    Gan; 1981 Aug; 72(4):531-8. PubMed ID: 7308664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.
    Mochizuki M; Osabe M; Anjo T; Suzuki E; Okada M
    J Cancer Res Clin Oncol; 1984; 108(3):290-5. PubMed ID: 6511803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure--activity studies on mutagenicity of nitrosamines using molecular connectivity.
    Kier LB; Simons RJ; Hall LH
    J Pharm Sci; 1978 May; 67(5):725-6. PubMed ID: 347051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of alpha-deuterium substitution on the mutagenicity of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Hecht SS; Lin D; Castonguay A
    Carcinogenesis; 1983; 4(3):305-10. PubMed ID: 6339096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system.
    Rinkus SJ; Legator MS
    Cancer Res; 1979 Sep; 39(9):3289-318. PubMed ID: 383284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenicity of alkyl-(omega-hydroxyalkyl) nitrosamines related to dibutylnitrosamine.
    Olajos EJ; Maverakis N; Cornish HH
    Mutat Res; 1978 Jan; 56(3):219-23. PubMed ID: 342939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenicity and cross-linking activity of chloroalkylnitrosamines, possible new antitumor lead compounds.
    Ishikawa S; Mochizuki M
    Mutagenesis; 2003 Jul; 18(4):331-5. PubMed ID: 12840106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational specificities of N-nitrosamines in a host-mediated assay: comparison with direct-acting N-nitroso compounds in vitro and an approach to deducing the nature of ultimate mutagens in vivo.
    Liu YX; Guttenplan JB
    Mol Carcinog; 1992; 6(4):232-7. PubMed ID: 1485914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenic activation of betel quid-specific N-nitrosamines catalyzed by human cytochrome P450 coexpressed with NADPH-cytochrome P450 reductase in Salmonella typhimurium YG7108.
    Miyazaki M; Sugawara E; Yoshimura T; Yamazaki H; Kamataki T
    Mutat Res; 2005 Mar; 581(1-2):165-71. PubMed ID: 15725615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo formation of N-nitroso compounds and detection of their mutagenic activity in the host-mediated assay.
    Braun R; Schöneich J; Ziebarth D
    Cancer Res; 1977 Dec; 37(12):4572-9. PubMed ID: 336196
    [No Abstract]   [Full Text] [Related]  

  • 39. Co-mutagenic effect of norharman with N-nitrosamine derivatives.
    Wakabayashi K; Nagao M; Kawachi T; Sugimura T
    Mutat Res; 1981 Jan; 80(1):1-7. PubMed ID: 7010130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of two suggested methods of deactivating organic carcinogens by molecular modification.
    Ashby J; Paton D; Lefevre PA; Styles JA; Rose FL
    Carcinogenesis; 1982; 3(11):1277-82. PubMed ID: 6758975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.